To investigate the ability to generate a therapeutic effect, the multicellular tumor spheroids were treated with Ru(II)-OH, NP2, or NP4 (10 M Ru) in a 1% or 21% O 2 atmosphere and afterward incubated with a cell live or death stain
Quick Reference: Standard Protocol Community-documented protocol: 250 mcg subcutaneous in the morning, 3 days per week, for 8-week cycles -- far below the 2.4 mg weekly clinical trial dose, reflecting conservative research-peptide practice
Glutathione is a powerful antioxidant produced naturally in the body, primarily in the liver
These formulation variables drive topical GHK-Cu dosage decisions
For research clarity, GHK-Cu wins: it is the better choice when you want a defined compound instead of a marketing blend
Typically, consistent daily use is recommended to maximize the benefits of the glutathione formula